Oppenheimer & Co. Inc. Has $757,000 Holdings in Addus HomeCare Co. (NASDAQ:ADUS)

Oppenheimer & Co. Inc. boosted its position in Addus HomeCare Co. (NASDAQ:ADUS) by 21.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,038 shares of the company’s stock after buying an additional 1,047 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Addus HomeCare were worth $757,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of ADUS. Quarry LP bought a new stake in Addus HomeCare in the 3rd quarter valued at $28,000. Farther Finance Advisors LLC boosted its holdings in Addus HomeCare by 9,150.0% in the 3rd quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock valued at $49,000 after purchasing an additional 366 shares during the period. KBC Group NV boosted its holdings in Addus HomeCare by 49.1% in the 4th quarter. KBC Group NV now owns 814 shares of the company’s stock valued at $102,000 after purchasing an additional 268 shares during the period. Assetmark Inc. boosted its holdings in Addus HomeCare by 11.5% in the 3rd quarter. Assetmark Inc. now owns 1,169 shares of the company’s stock valued at $156,000 after purchasing an additional 121 shares during the period. Finally, GAMMA Investing LLC boosted its holdings in Addus HomeCare by 34.5% in the 4th quarter. GAMMA Investing LLC now owns 1,258 shares of the company’s stock valued at $158,000 after purchasing an additional 323 shares during the period. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Addus HomeCare Stock Up 2.3 %

Shares of Addus HomeCare stock opened at $96.19 on Thursday. The stock has a market capitalization of $1.75 billion, a P/E ratio of 22.01, a price-to-earnings-growth ratio of 1.41 and a beta of 0.97. The company has a 50-day simple moving average of $120.52 and a 200 day simple moving average of $125.32. Addus HomeCare Co. has a 12-month low of $87.88 and a 12-month high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, February 24th. The company reported $1.26 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.35 by ($0.09). The firm had revenue of $297.14 million for the quarter, compared to analyst estimates of $291.04 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. On average, equities analysts anticipate that Addus HomeCare Co. will post 4.59 earnings per share for the current year.

Wall Street Analyst Weigh In

ADUS has been the subject of a number of research reports. StockNews.com downgraded shares of Addus HomeCare from a “buy” rating to a “hold” rating in a report on Wednesday, February 26th. Macquarie reissued an “outperform” rating and issued a $129.00 price target on shares of Addus HomeCare in a report on Thursday, February 27th. Citizens Jmp raised shares of Addus HomeCare to a “strong-buy” rating in a report on Monday, December 16th. Stephens reduced their price objective on shares of Addus HomeCare from $153.00 to $142.00 and set an “overweight” rating for the company in a report on Wednesday, February 26th. Finally, JMP Securities assumed coverage on shares of Addus HomeCare in a report on Monday, December 16th. They set an “outperform” rating and a $150.00 price objective for the company. One research analyst has rated the stock with a sell rating, one has given a hold rating, seven have issued a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $132.78.

Insider Buying and Selling

In other Addus HomeCare news, CEO R Dirk Allison sold 25,000 shares of the firm’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $124.76, for a total value of $3,119,000.00. Following the completion of the sale, the chief executive officer now owns 79,397 shares in the company, valued at approximately $9,905,569.72. This trade represents a 23.95 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Roberton James Stevenson sold 2,250 shares of the firm’s stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $121.00, for a total transaction of $272,250.00. Following the completion of the sale, the executive vice president now owns 10,217 shares of the company’s stock, valued at $1,236,257. The trade was a 18.05 % decrease in their position. The disclosure for this sale can be found here. 4.60% of the stock is currently owned by corporate insiders.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.